Institute of Post Graduate Medical Education & Research Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4

Organization Overview

First Clinical Trial
2008
NCT00694915
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Institute of Post-Graduate Medical Education and Research, Kolkata | Institute of Post Graduate Medical Education & Research, S. S. K. M. Hospital | IPGMER, Kolkatta | IPGMER, S.S.K.M. Hospital | Pt BO Sharma,PGIMS/UHS. Rohtak, Haryana

Active Ingredients

Drugs in Phase 4 Trials (1)

insulin glargine (toujeo) (1 trial)

Drugs in Phase 3 Trials (2)

imidazoquinoline (1 trial)

tadalafil (cialis) (1 trial)

Drugs in Phase 2 Trials (2)

bacille calmette-guerin (1 trial)

mycobacterium w vaccine (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma (Phase 2)

Carcinoma, Transitional Cell (Phase 2)

Coronavirus Infections (Phase 3)

Diabetic Foot (Phase 4)

Foot Ulcer (Phase 4)

Raynaud Disease (Phase 3)

Scleroderma, Diffuse (Phase 3)

Scleroderma, Localized (Phase 3)

Scleroderma, Systemic (Phase 3)

Severe Acute Respiratory Syndrome (Phase 3)

Ulcer (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 5